Introduction 42
Morphine-induced addictive behaviors are strongly dependent on the activation of 43 dopamine (DA) neurons of the ventral tegmental area (VTA) (Wise, 1989, Gardner, 44 2011, Luscher and Malenka, 2011) . One previously reported mechanism for morphine 45 to activate VTA-DA neurons is the disinhibition model of VTA-DA neurons (Johnson 46 and North, 1992, Kalivas, 1993 , White, 1996 . Recently, we found that morphine could 47 promote presynaptic glutamate release of VTA-DA neurons, which constituted the 48 main mechanism for morphine-induced increase in VTA-DA neurons firing and related 49 behaviors (Chen et al., 2015) . However, what source of presynaptic glutamate release 50 of DA neurons in the VTA is promoted by morphine remains unknown. 51 It has been known that DA neurons of the VTA receive glutamatergic inputs from 52 the medial prefrontal cortex (mPFC), the bilateral amygdala (BLA) and the lateral 53 hypothalamus (LH) (Stuber et al., 2012 , Li et al., 2013 . To study which glutamatergic 54 inputs onto DA neurons of the VTA are modulated by morphine, we used optogenetic 55 strategy to selectively activate glutamatergic inputs from these different projection 56 neurons and then observed the effect of morphine on them. We also studied the 57 contribution of morphine-induced increase in presynaptic glutamate release of DA 58 neurons in the VTA from specific brain region to morphine-induced increase in 59 locomotor activity of mice, which is an index of enhanced DA function in the VTA 60 (Jalabert et al., 2011) . 61 the VTA (Penzo et al., 2015) , followed by the injection of the AAV-DIO-hM4Di-mCherry 108 into the mPFC. Six weeks after the infection, the expression of 109 AAV-DIO-hM4D(Gi)-mCherry was observed in the mPFC (left panel of Here, we find that morphine selectively promotes glutamate release from 156 glutamatergic terminals of projection neurons from the mPFC to the VTA, but has no 157 effect on that from the BLA or the LH to the VTA. This result suggests that morphine 158 may mainly acts at glutamatergic terminals of projection neurons from the mPFC to 159 the VTA to activate DA neurons of the VTA. This result is consistent with the report 160 that the microinjection of morphine into the mPFC cannot produce rewarding effects 161 (Liu et al., 2015) because the site of action of morphine on mPFC-VTA glutamatergic 162 projection neurons is at terminals, rather than at the cell body in the mPFC. 163 What needs to be explained is that in our previous study in the VTA (Chen et al., 164 2015), when we use a pair of electrical pulses at intervals of 50 ms at 0.1 Hz to evoke 165 EPSC, it always produces paired pulse facilitation, but here when we use a pair of 166 optical pulses at intervals of 50 ms at 0.1 Hz to evoke EPSC in the VTA, it always 167 produces paired pulse depression. This phenomenon also existed in the study by and placed in modified ACSF containing 75 mM sucrose, 88 mM NaCl, 2.5 mM KCl, 203
1.25 mM NaH2PO4, 7 mM MgCl2, 0.5 mM CaCl2, 25 mM NaHCO3, and saturated with 204 95% O2 and 5% CO2 at ∼0˚C. Horizontal 250 μm midbrain slices containing VTA were 205 cut on a vibratome (VT-1200, Leica, Wetzlar, Germany) and transferred to normal 206 ACSF containing 126 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 2 mM MgSO4, 2.5 207 mM CaCl2, 25 mM NaHCO3, and 10 mM glucose at 32˚C. Slices were incubated for at 208 least 60 min before patch-clamp recording. 209
210

In vitro Optogenetics approach for electrophysiology 211
The medial terminal nucleus of the accessory optic tract (MT) was used as the 212 anatomical structure to define the VTA (Hopf et al., 2007) . VTA neurons were 213 visualized on an upright microscope (BX50WI, Olympus, Tokyo, Japan) using infrared 
Locomotor behavior 237
The locomotor activity test was conducted as described previously with some 238 modifications (Borgland et al., 2006) . The locomotor activity of animals was monitoredwith a near infrared video camera within the operant chambers (Med Associates, St. 240
Albans, USA). Distance traveled was measured using Open Field Activity Software 241 (Med Associates) and analyzed locomotion estimates based on movement over a 242
given distance and resting delays (movement in a given period of time). All animals 243
were habituated to the test room for 2 h prior to the start of the experiment. Mice were 244 habituated to the operant chambers for 5 min after 15 min intraperitoneal injection. 245 After 15 minutes drug administration, the mice were placed in the chambers for the 5 246 min testing session. On days 1, 2, and 3, all mice were only given saline 247 (intraperitoneal injections) to habituate them to the test protocol. On day 4, mice were 248
given drugs according to experimental group. After the behavioral tests, all mice were 249 anesthetized with an overdose of chloral hydrate and perfused with 0.9% saline. 
Data analysis 264
Numerical data were expressed as mean ± SE. Off-line data analysis was performed 265 using a Mini Analysis Program (Synaptosoft), Clampfit (Axon Instruments), SigmaPlot 266 (Jandel Scientific) and Origin (Microcal Software). Statistical significance was 267 determined using Student's t-test for comparisons between two groups or ANOVA 268 followed by Student-Newman-Keuls test for comparisons among three or more 269 groups, n refers to the number of cells. Every cell was from different slice and a group 270 of cells in each experiment was from at least 5 animals. All post hoc comparisons 271 were made using Tukey's test. Results with P < 0.05 were accepted as being 272 statistically significant. 
